On this Page
- What is a Protocol Violation?
- When do Protocol Violations Occur?
- How Clinion Helps Manage Protocol Violations
- What it looks like in practice
- Related Terms
- Related Articles
- Category
- What is a Protocol Violation?
- When do Protocol Violations Occur?
- How Clinion Helps Manage Protocol Violations
- What it looks like in practice
- Related Terms
- Related Articles
- Category
What is a Protocol Violation?
A protocol violation is a significant non-compliance with the approved clinical trial protocol, regulatory requirements, or Good Clinical Practice (GCP) guidelines that may affect participant safety, rights, or data integrity. Protocol violations are generally considered more serious than protocol deviations and often require formal reporting and corrective action.
When do Protocol Violations Occur?
Protocol violations can occur during study conduct when approved procedures, eligibility requirements, or safety guidelines are not followed correctly. Common examples include enrollment of ineligible participants, incorrect dosing, missed safety assessments, or failure to obtain proper informed consent.
Because protocol violations can affect participant safety and study validity, they are typically reviewed and assessed by sponsors and study teams. Depending on the severity of the event, additional corrective actions or reporting to regulatory authorities and ethics committees may also be required.
How Clinion Helps Manage Protocol Violations
Clinion helps study teams identify and manage potential protocol violations through AI-enabled review capabilities and connected clinical workflows within its unified eClinical platform. AI-driven checks can help flag missing assessments, out-of-window visits, inconsistent study data, or potential protocol non-compliance that may require further review.
Centralized visibility across study records, audit trails, and operational activities also helps teams maintain traceability and oversight while managing protocol-related issues during study conduct.
What it looks like in practice
A clinical study may require that only participants meeting specific eligibility criteria are enrolled in the trial. During the study, a research site might mistakenly enroll a participant who does not meet the approved inclusion criteria outlined in the protocol.
The event could then be classified as a protocol violation, requiring sponsor review, participant impact assessment, documentation, and appropriate corrective action based on study and regulatory requirements.
Related Terms
Informed Consent Form (ICF)
Corrective and Preventive Action (CAPA)
Related Articles
Category
Study Setup & Design